Latest Capital Funding News

MAAS Group Holdings reconfirms FY26 EBITDA guidance, reports 35% completion on a $200 million AI factory electrical contract, progresses $1.7 billion construction materials sale, and expands debt facilities to support growth.

Savannah Goldfields has secured $3.5 million through a $1.5 million equity placement at a 31.5% premium and a $2 million tiered royalty sale to fund the Agate Creek mine restart and ongoing operations.

Native Mineral Resources (ASX:NMR) has raised A$3.5 million through a convertible note with existing investor Lind Global Fund III LP, aiming to reduce debt and support operational cash flow.

MC Mining has secured a US$90 million capital injection from Kinetic Development Group, which now holds a 51% controlling stake, accelerating the Makhado Project towards production. New board appointments signal a strategic shift as the company pivots from development to operational ramp-up.

KGL Resources has secured a US$300 million streaming agreement with Wheaton Precious Metals, unlocking early construction funding for its Jervois Copper-Silver-Gold Project. The updated Baseline Economic Model highlights robust returns with a post-tax NPV8 of A$839 million and a 30% IRR, underpinning the path to production.

Investigator Silver has locked in a robust Definitive Feasibility Study for its Paris Silver Project, backed by a strategic A$55 million placement to fast-track early works and financing.

GreenTech Metals has consolidated a dominant West Pilbara position by acquiring 70% of the Munni Munni PGE-Cu-Ni Project and completed a cost-saving Phase 1 drilling and historic core resampling program. Early data hints at significant resource expansion ahead of a JORC 2012 upgrade.

Resolution Minerals has raised A$20 million in a strongly supported institutional placement to accelerate exploration and development at its US Horse Heaven Project, while preparing for a NASDAQ listing to boost its US market presence.

European Resources Limited (ASX: ERE) has repriced and relaunched a renounceable rights issue to raise up to $3.4 million, partially underwritten by Mahe Capital for $1.5 million, to fund metallurgical and exploration work at its Korsnäs rare earth project in Finland and Slovakian tenements.

Bailador Technology Investments is backing DASH Technology Group with an additional $5 million investment at a valuation below its current carrying value, reflecting cautious optimism amid market pressures.

Chimeric Therapeutics has secured a $1.785 million advance against its anticipated FY26 Research and Development Tax Incentive to bolster its clinical trial pipeline and working capital.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.